RS77704A - Postupak za dobijanje kristalnog oblika 1 kabergolina - Google Patents

Postupak za dobijanje kristalnog oblika 1 kabergolina

Info

Publication number
RS77704A
RS77704A YU77704A YUP77704A RS77704A RS 77704 A RS77704 A RS 77704A YU 77704 A YU77704 A YU 77704A YU P77704 A YUP77704 A YU P77704A RS 77704 A RS77704 A RS 77704A
Authority
RS
Serbia
Prior art keywords
cabergoline
toluene
solvate
gel
heptane
Prior art date
Application number
YU77704A
Other languages
English (en)
Serbian (sr)
Inventor
Ahmad Sheikh
Original Assignee
Pharmacia Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corporation filed Critical Pharmacia Corporation
Publication of RS77704A publication Critical patent/RS77704A/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06Lysergic acid amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU77704A 2002-03-15 2003-03-10 Postupak za dobijanje kristalnog oblika 1 kabergolina RS77704A (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36456702P 2002-03-15 2002-03-15
US41025302P 2002-09-12 2002-09-12
PCT/US2003/007138 WO2003078392A2 (en) 2002-03-15 2003-03-10 Process for preparing crystalline form i of cabergoline

Publications (1)

Publication Number Publication Date
RS77704A true RS77704A (sr) 2006-10-27

Family

ID=28045415

Family Applications (1)

Application Number Title Priority Date Filing Date
YU77704A RS77704A (sr) 2002-03-15 2003-03-10 Postupak za dobijanje kristalnog oblika 1 kabergolina

Country Status (14)

Country Link
EP (1) EP1507777A4 (pl)
JP (1) JP2005520831A (pl)
KR (1) KR100605794B1 (pl)
CN (1) CN1642953A (pl)
AU (1) AU2003224665A1 (pl)
BR (1) BR0308472A (pl)
CA (1) CA2478149A1 (pl)
IL (1) IL163779A0 (pl)
MX (1) MXPA04008935A (pl)
PL (1) PL372371A1 (pl)
RS (1) RS77704A (pl)
RU (1) RU2277536C2 (pl)
TW (1) TW200306312A (pl)
WO (1) WO2003078392A2 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL155545A (en) 2003-04-21 2009-12-24 Finetech Pharmaceutical Ltd Solvate form of cabergoline
EP1620101A4 (en) * 2003-05-08 2008-07-09 Ivax Pharmaceuticals Sro POLYMORPHS OF CABERGOLIN
GB0409785D0 (en) * 2004-04-30 2004-06-09 Resolution Chemicals Ltd Preparation of cabergoline
US7339060B2 (en) 2005-03-23 2008-03-04 Resolution Chemicals, Ltd. Preparation of cabergoline
GB0515430D0 (en) * 2005-07-27 2005-08-31 Resolution Chemicals Ltd Preparation of cabergoline
GB0505965D0 (en) 2005-03-23 2005-04-27 Resolution Chemicals Ltd Preparation of cabergoline
EP1953157A1 (en) 2007-01-31 2008-08-06 LEK Pharmaceuticals D.D. New crystal form of cabergoline

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526892A (en) * 1981-03-03 1985-07-02 Farmitalia Carlo Erba, S.P.A. Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas
GB0007308D0 (en) * 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Process for preparing crystalline form | of cabergoline
MXPA04008915A (es) * 2002-03-15 2005-06-20 Pharmacia Corp Proceso para la preparacion de la forma cristalina 1 de la cabergolina.

Also Published As

Publication number Publication date
WO2003078392A2 (en) 2003-09-25
RU2277536C2 (ru) 2006-06-10
MXPA04008935A (es) 2004-11-26
TW200306312A (en) 2003-11-16
KR20050002858A (ko) 2005-01-10
CA2478149A1 (en) 2003-09-25
EP1507777A4 (en) 2007-03-07
AU2003224665A1 (en) 2003-09-29
RU2004127582A (ru) 2006-01-27
EP1507777A2 (en) 2005-02-23
BR0308472A (pt) 2005-01-11
PL372371A1 (pl) 2005-07-25
IL163779A0 (en) 2005-12-18
WO2003078392A3 (en) 2003-12-11
KR100605794B1 (ko) 2006-08-01
JP2005520831A (ja) 2005-07-14
CN1642953A (zh) 2005-07-20

Similar Documents

Publication Publication Date Title
TWI379681B (en) Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof
CA2793312C (en) Anhydrous lenalidomide form-i
JP4184666B2 (ja) カベルゴリンの結晶性形態iを調製するための方法
RS77704A (sr) Postupak za dobijanje kristalnog oblika 1 kabergolina
RU2278118C2 (ru) Способ получения кристаллических форм i или v каберголина, способ получения сольватированной формы v каберголина
JP2006521340A (ja) ロシグリタゾン・マレイン酸塩の多形体の製法
ZA200406588B (en) Process for preparing crystalline form I of cabergoline
WO2009150524A1 (en) Process for preparing a benzoylbenzeneacetamide derivative
WO2011055233A2 (en) Improved process for preparing celecoxib polymorph
HK1075047A (en) Process for preparing crystalline form i of cabergoline
CN115785089A (zh) 一种利奥西呱杂质c的合成方法
EP1953157A1 (en) New crystal form of cabergoline
EP1925616A1 (en) Process for the preparation of crystal forms of cabergoline via stable solvates of cabergoline